Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma [Phase 1]
Phase 1 clinical trial evaluating the safety and biological effects of intratumoral interferon gamma and a peptide-based vaccine in patients…
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma [Phase 1]
Phase 1 trial evaluating the combination of topical imiquimod and a multipeptide vaccine for cutaneous metastases of melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor [Phase 2]
Open-label Phase II trial evaluating the combination of dabrafenib (GSK2118436) and trametinib (GSK1120212) in metastatic melanoma refractor…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma [Phase 2]
Phase 2 trial evaluating nilotinib in patients with metastatic mucosal, acral, or chronically sun-damaged melanoma who are resistant or into…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients [Phase 1]
Phase 1 study evaluating natural dendritic cell vaccines in metastatic melanoma patients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Disulfiram in Patients With Metastatic Melanoma [Phase 1, Phase 2]
This document reports on a completed Phase 1/2 clinical trial evaluating disulfiram in patients with metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2016-11-25Clinical Trial Update: Prospective Measurement of Post-Treatment Lymphedema
A completed clinical trial from MD Anderson Cancer Center investigating prospective measurement of post-treatment lymphedema in melanoma pat…
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV Melanoma [Phase 1, Phase 2]
A Phase 1/Phase 2 trial of A-dmDT390-bisFv(UCHT1) fusion protein in combination with ionizing radiation for stage IV melanoma has been termi…
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: IMCgp100 in Advanced Unresectable Melanoma [EARLY_Phase 1]
The update reports the completion of an early-phase (Phase 1) trial of IMCgp100 (tebentafusp) in advanced, unresectable melanoma.
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Melanoma Perception and Health Literacy in People of Color [NA]
A completed clinical trial evaluating melanoma perception and health literacy in people of color, with results posted.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics
This is a completed non-interventional study sponsored by Hoffmann-La Roche that assesses the occurrence rates of several cancers in Turkey …
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: MSB0010445 and Stereotactic Body Radiation Therapy in Advanced Melanoma [Phase 2]
A Phase 2 study evaluating MSB0010445 in combination with stereotactic body radiation therapy for advanced melanoma was terminated, with res…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Nevus Doctor Clinical Decision Support [NA]
A completed clinical trial evaluating the Nevus Doctor Clinical Decision Support system for dermatologic conditions including nevus and mela…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma [Phase 1, Phase 2]
This update reports on the completed Phase 1/2 study of ALT-801 in combination with cisplatin for metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial of a vaccine therapy with or without recombinant interleukin-12 followed by daclizumab in metastatic melanoma was terminated. …
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: 0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma [Phase 2]
Phase 2 trial investigating pentamidine in patients with relapsed or refractory melanoma was terminated; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Safety and Efficacy of Combination HDI and Anti-CTLA4 for Recurrent Inoperable Stage III or Stage IV Melanoma [Phase 2]
A Phase 2 trial evaluated the safety and efficacy of combining High-Dose Interferon alfa-2b with an anti-CTLA-4 antibody in patients with re…
-
CLINICAL_TRIALS trial_result · 2016-10-10Clinical Trial Update: E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma [Phase 1, Phase 2]
This clinical trial update reports results from a Phase 1/2 study evaluating lenvatinib in combination with dacarbazine versus dacarbazine a…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-041/KEYNOTE-041) [Phase 1]
Phase 1 study of pembrolizumab in advanced melanoma completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: A Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma [Phase 2]
A single-arm Phase 2 trial evaluating ipilimumab monotherapy in patients with previously treated unresectable stage III or IV melanoma.
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection [Phase 1]
A multicenter Phase I study of MRX34 liposomal injection (miR-34a mimic) across several cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-13Clinical Trial Update: Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma. [Phase 1, Phase 2]
This clinical trial update reports safety and efficacy data for LEE011 and LGX818 in patients with BRAF-mutant melanoma (Phase 1/2). The stu…
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma [Phase 2]
Phase 2 trial of dasatinib in acral lentiginous, mucosal, or chronic sun-damaged melanoma was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer [Phase 1]
A Phase 1 study of a recombinant hGM-CSF–expressing herpes simplex virus for cancer treatment has completed Phase 1, indicating initial safe…
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Clinical and Histological Features of Head and Neck Melanoma
This completed clinical trial update describes the clinical and histological features of head and neck melanoma.